Innophys Launches Sales of "Muscle Suit (R)" Powered Exoskeletons in Singapore

2025-02-06 IDOPRESS

- Addressing Needs of Aging Population and Reducing Workload,Aiming for Expansion in Southeast Asian Markets -

TOKYO,Jan. 27,2025 -- Innophys Co.,Ltd. (hereinafter referred to as "Innophys"),a venture originating from Tokyo University of Science,located in Hachioji City,Tokyo,started sales in Singapore of its Muscle Suit (R) powered exoskeleton series on January 6.

Image1:


https://cdn.kyodonewsprwire.jp/prwfile/release/M106291/202501223205/_prw_PI1fl_V3mwXd0T.jpg

Innophys launched the lightweight model "Muscle Suit Soft-Power EASY-LIFT" in October last year. The company is progressing with its market expansion,tailoring its offerings to meet local needs.

Following its foray into Romania last year,Innophys has begun selling its Muscle Suit (R) in Singapore as part of its efforts to strengthen its presence in overseas markets. Singapore boasts a high economic standard and is proactive in enhancing labor conditions,adopting advanced technologies. Additionally,as an important logistics hub,Singapore has seen rising interest in the Muscle Suit (R) series for tasks such as cargo handling in factories and warehouses,as well as in the healthcare and caregiving sectors.

The country faces a growing need to address the aging population and reduce labor burdens. Through the Muscle Suit (R) model,Innophys aims to improve worker safety and productivity. Singapore is positioned as a hub for the Southeast Asian market. By leveraging the country as a base,Innophys is committed to further expanding into additional overseas markets.

The current overseas Muscle Suit (R) distributors are located in the following countries/regions (as January 27,2025):

- Asia: Mainland China,South Korea,Taiwan region,Hong Kong SAR & Macau SAR,Malaysia,Thailand,Singapore

- EU: France,Spain,Italy,Germany,Poland,Denmark,Estonia,Latvia,Lithuania,Romania,Czech Republic,Slovakia,Slovenia

- Latin America: Mexico

Official global websites of Muscle Suit (R):


Muscle Suit: https://innophys.net/musclesuit/


Information on oversea distributors: https://innophys.net/musclesuit/distributors-and-retailers/

About Muscle Suit Soft-Power EASY-LIFT

Image2:


https://cdn.kyodonewsprwire.jp/prwfile/release/M106291/202501223205/_prw_PI2fl_72dluVqM.jpg

Released on October 21,2024,this entry-level model is designed for tasks like farming,construction,and transport,reducing lower back strain by 33%. Weighing only 310g,it is lightweight,flexible,easy to wear,washable,and affordable,making it highly practical for users.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map